EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Association between Clinicopathological Features and BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis and Systematic Review

Tao Fu, Jiahao Chen, Xiaxia Jin, Yingzheng Gao, Weidong Du

Oncology · 19.05.2026 · 1-14

DOI: 10.1159/000551991 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Oncology, online erschienen am 19.05.2026. Verfasst von Tao Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Thyroid Cancer, Papillary, Thyroid Neoplasms, Mutation. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The association between BRAF V600E mutation and clinicopathological features of papillary thyroid carcinoma (PTC) remains controversial. This study aimed to explore its prognostic value via meta-analysis.

Methods

Databases including PubMed, Cochrane Library, Embase, and Web of Science were systematically searched for studies published before June 1, 2025. Pooled odds ratio (OR) with 95% confidence interval (CI) was used as the effect size, analyzed by R 4.4.2.

Results

A total of 26 studies (2010–2024) involving 13,999 patients were included. BRAF V600E mutation was significantly positively associated with capsular invasion (OR = 1.80, 95% CI: 1.16–2.78) and extrathyroidal extension (OR = 1.62, 95% CI: 1.36–1.94), and negatively associated with concomitant Hashimoto’s thyroiditis (OR = 0.55, 95% CI: 0.32–0.94). A marginal association trend was observed with gender, with male patients showing a higher likelihood of harboring the BRAF V600E mutation (OR = 1.26, 95% CI: 1.10–1.44, p = 0.0525), while no significant associations were found with age, tumor size, multifocality, central or lateral lymph node metastasis.

Conclusion

BRAF V600E mutation correlates with specific clinicopathological features of PTC and serves as a potential prognostic predictor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafThyroid Cancer, PapillaryThyroid NeoplasmsMutationHumansPrognosisMaleFemaleLymphatic Metastasis

Stichwörter der Autor:innen

BRAF V600E mutationClinicopathological featuresMeta-analysisPapillary thyroid carcinomaPrognosis

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
  • Taizhou Nursing School, Taizhou, China.
  • The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China, doctordu@sina.cn.

Zitieren

APA

Fu, T., Chen, J., Jin, X., Gao, Y., & Du, W. (2026). Association between Clinicopathological Features and BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis and Systematic Review. Oncology, 1-14. https://doi.org/10.1159/000551991

Vancouver

Fu T, Chen J, Jin X, Gao Y, Du W. Association between Clinicopathological Features and BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis and Systematic Review. Oncology. 2026:1-14. doi:10.1159/000551991

BibTeX
@article{Fu2026,
  author = {Fu, Tao and Chen, Jiahao and Jin, Xiaxia and Gao, Yingzheng and Du, Weidong},
  title = {Association between Clinicopathological Features and BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis and Systematic Review},
  journal = {Oncology},
  year = {2026},
  pages = {1--14},
  doi = {10.1159/000551991}
}
Kostenlos starten →